The FDA's decision on Aug. 9, 2024, not to approve MDMA to treat PTSD marks a blow to a small but growing number of employers offering healthcare coverage for psychedelic drugs to treat mental health issues like depression.
Awareness and access remain obstacles preventing lower-income workers from taking advantage of employee wellbeing benefits. Experts share what HR can do.
While embracing flexibility enhances agility, reduces costs and broadens the talent pool, it also requires thoughtful planning, a robust tech stack and a commitment to an inclusive and adaptive workplace culture.
As screening practices evolve and employees look for cost savings, employers will see more requests for enhanced breast cancer screening benefits, these experts write.
Employees want coverage for GLP-1 drugs but employers continue to struggle with the high costs. Here's what HR leaders need to think about before crafting a strategy.
